Eurostoside

Eurostoside

SCHEMBL29425819

O=C(/C=C/c1ccc(O)cc1)OCC1=C[C@@H](O)[C@@H]2C=CO[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@H]12

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 1/20 0.62
▸ HSP90AA1 P07900 7/20 0.59
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ XDH P47989 1/20 0.50
▸ ELANE P08246 1/20 0.47
▸ CA12 O43570 2/20 0.45
▸ CA1 P00915 2/20 0.45
▸ CA2 P00918 2/20 0.45
▸ CA4 P22748 2/20 0.45
▸ CA5A P35218 2/20 0.45
▸ CA7 P43166 2/20 0.45
▸ CA9 Q16790 2/20 0.45
▸ CA3 P07451 1/20 0.45
▸ CA13 Q8N1Q1 1/20 0.45
▸ CA14 Q9ULX7 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ GLA P06280 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ TSHR P16473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29425984 0.89 L3MBTL1 (0.54) L3MBTL1HSP90AA1ELANECA12CA1
Agnuside SCHEMBL13208121 0.85 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHCA12CA1
Agnuside SCHEMBL24174405 0.85 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHCA12CA1
Agnuside SCHEMBL382107 0.85 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHCA12CA1
SCHEMBL30561993 0.84 HSP90AA1 (0.62) L3MBTL1HSP90AA1SMN1; SMN2XDHELANE
SCHEMBL29503004 0.82 L3MBTL1 (0.62) L3MBTL1HSP90AA1XDHELANECA12
SCHEMBL14010921 0.81 CA12 (0.41) L3MBTL1HSP90AA1SMN1; SMN2CA12CA1
SCHEMBL7153129 0.80 L3MBTL1 (0.67) L3MBTL1HSP90AA1XDHCA12CA1
SCHEMBL13998203 0.78 CA12 (0.46) HSP90AA1SMN1; SMN2CA12CA1CA2
SCHEMBL29425914 0.78 HSP90AA1 (0.63) L3MBTL1HSP90AA1SMN1; SMN2XDHELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4702037-A1 METHOD OF PRODUCING IRIDOIDS Nicoventures Trading Limited (GB) 2026-03-04 — — EP disclosed
WO-2024224085-A1 METHOD OF PRODUCING IRIDOIDS Nicoventures Trading Limited (GB) 2024-10-31 — — WO disclosed
CN-115607646-A Composition for treating recurrent oral ulcer and chronic pharyngolaryngitis and preparation method thereof 青川县竹园镇中心卫生院 2023-01-17 — — CN disclosed
EP-3409766-B1 AN ESTERASE THAT IS CAPABLE OF CONVERTING IRIDOIDS AND SECO-IRIDOIDS N ZYME BIOTEC GMBH (DE) 2022-03-09 — — EP disclosed
Send feedback